Indian Stocks Face Valuation Challenge Over Tariff Concerns
Indian equity markets significantly underperformed in 2025, with MSCI India gaining just 2.5% versus 28% for emerging markets, primarily due to elevated valuations and slowing earnings rather than tariff concerns. Indian stocks trade at 25.2 times trailing earnings compared to 16.2 times for emerging markets as of October 2025, while corporate profit growth slowed in FY25 and early FY26. Other emerging markets like Taiwan and China delivered stronger returns despite similar trade pressures, indicating domestic fundamentals are the key challenge for Indian equities.

*this image is generated using AI for illustrative purposes only.
Indian equity markets have delivered disappointing returns in 2025, significantly underperforming emerging market peers despite widespread attribution of the weakness to U.S. tariff concerns. However, market data reveals that domestic factors, particularly elevated valuations and slowing earnings growth, present more substantial challenges than external trade pressures.
Performance Gap Widens with Emerging Markets
The performance divergence between Indian stocks and global emerging markets has reached notable proportions. In calendar year 2025, the MSCI India index posted modest returns of around 2.5% in U.S. dollar terms, while the broader MSCI Emerging Markets index surged nearly 28% over the same period, marking one of the widest performance gaps in decades.
| Market Index | 2025 Performance | Period |
|---|---|---|
| MSCI India | 2.5% | Calendar Year 2025 |
| MSCI Emerging Markets | 28% | Calendar Year 2025 |
| Taiwan TAIEX | 35% | Past One Year |
| China SSE Composite | 28% | Past One Year |
| India Sensex | 7% | Past One Year |
This underperformance extends to local indices, where Taiwan's TAIEX gained around 35% over the past year and China's SSE Composite Index rose about 28%, while India's Sensex grew by just 7%. The divergence is particularly striking given that these markets have faced comparable tariff and trade-related pressures.
Valuation Premium Remains Elevated
A critical factor behind India's weaker performance lies in expensive valuations relative to emerging market peers. As of October 2025, Indian equities continue trading at significant premiums, with the MSCI India index valued at around 25.2 times trailing earnings compared to approximately 16.2 times for the MSCI Emerging Markets index.
| Valuation Metric | MSCI India | MSCI Emerging Markets |
|---|---|---|
| Trailing P/E Ratio (October 2025) | 25.2x | 16.2x |
| Valuation Premium | Elevated | Baseline |
This valuation gap reduces the margin of safety for investors and amplifies sensitivity to any negative developments. The premium has also influenced capital flows, with analysts noting inconsistent foreign portfolio investment into Indian equities as global funds seek better risk-reward ratios in cheaper markets.
Earnings Growth Momentum Slows
Corporate earnings performance has added pressure to the valuation challenge. Profit growth for major Indian companies slowed materially in FY25 and early FY26, reducing the earnings upgrades that traditionally support higher equity valuations. This deceleration occurred just as markets were already elevated from years of strong performance.
In contrast, other emerging markets have benefited from sector-specific tailwinds. Taiwan's technology sector has gained significantly from global semiconductor demand, while Mexico has enjoyed nearshoring investment flows that boosted investor sentiment. These earnings differentials help explain the outperformance of these markets despite challenging global conditions.
Limited Tariff Impact on Fundamentals
While U.S. tariffs introduced in mid-2025 disrupted trade flows and triggered short-term volatility in export-sensitive sectors like pharmaceuticals, textiles, and jewelry, the direct macroeconomic impact remains limited. India's exports to the United States account for a relatively small share of GDP compared to China's much larger trade exposure.
Moody's Ratings warned that higher U.S. tariffs could hamper India's manufacturing push and project a modest drag on GDP growth. However, the stronger performance of other emerging markets facing similar trade pressures suggests that tariff concerns alone cannot explain India's relative underperformance.
Market Outlook Challenges
The combination of high valuations and slowing earnings growth leaves Indian markets vulnerable to disappointments. Post-Covid easy liquidity conditions that fueled sustained rallies have normalized, with markets now demanding stronger corporate earnings to justify elevated multiples. The Reserve Bank of India's relatively higher interest rates compared to some global peers have also made equities less attractive relative to other asset classes.
Until corporate earnings demonstrate clear and sustained recovery or valuations adjust to more comfortable levels, Indian equities are likely to remain sensitive to both global developments and domestic challenges, with fundamentals rather than tariff headlines driving performance.

































